120 related articles for article (PubMed ID: 8268033)
21. Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin.
Krebs-Thomson K; Lehmann-Masten V; Naiem S; Paulus MP; Geyer MA
Eur J Pharmacol; 1998 Feb; 343(2-3):135-43. PubMed ID: 9570460
[TBL] [Abstract][Full Text] [Related]
22. Behavioral evidence for differential adaptation of the serotonergic system after acute and chronic treatment with (+/- )-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) or ketanserin.
Darmani NA; Martin BR; Glennon RA
J Pharmacol Exp Ther; 1992 Aug; 262(2):692-8. PubMed ID: 1501117
[TBL] [Abstract][Full Text] [Related]
23. Role of serotonergic input to the ventrolateral medulla in expression of the 10-Hz sympathetic nerve rhythm.
Orer HS; Gebber GL; Barman SM
Am J Physiol Regul Integr Comp Physiol; 2008 May; 294(5):R1435-44. PubMed ID: 18337315
[TBL] [Abstract][Full Text] [Related]
24. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells.
Ferry RC; Unsworth CD; Molinoff PB
Mol Pharmacol; 1993 May; 43(5):726-33. PubMed ID: 8388988
[TBL] [Abstract][Full Text] [Related]
25. Central and peripheral mechanisms in the stimulation of adrenocortical secretion by the 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane.
Welch JE; Saphier D
J Pharmacol Exp Ther; 1994 Sep; 270(3):918-28. PubMed ID: 7932204
[TBL] [Abstract][Full Text] [Related]
26. The role of serotonin receptor subtypes in the behavioural effects of neuroleptic drugs. A paw test study in rats.
Ellenbroek BA; Prinssen EP; Cools AR
Eur J Neurosci; 1994 Jan; 6(1):1-8. PubMed ID: 7907518
[TBL] [Abstract][Full Text] [Related]
27. 5-HT2 receptor agonists increase spontaneous sympathetic nerve discharge.
McCall RB; Harris LT
Eur J Pharmacol; 1988 Jun; 151(1):113-6. PubMed ID: 3416918
[TBL] [Abstract][Full Text] [Related]
28. Further evidence for enigmas in adaptation mechanisms for the DOI-induced behaviors.
Darmani NA
Pharmacol Biochem Behav; 1992 Nov; 43(3):765-70. PubMed ID: 1448470
[TBL] [Abstract][Full Text] [Related]
29. 5-HT and carbohydrate suppression: effects of 5-HT antagonists on the action of d-fenfluramine and DOI.
Lawton CL; Blundell JE
Pharmacol Biochem Behav; 1993 Oct; 46(2):349-60. PubMed ID: 8265689
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the 5-HT2 receptor ligands dimethoxy-4-indophenyl-2-aminopropane and ketanserin in ethanol discriminations.
Szeliga KT; Grant KA
Alcohol Clin Exp Res; 1998 May; 22(3):646-51. PubMed ID: 9622445
[TBL] [Abstract][Full Text] [Related]
31. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
[TBL] [Abstract][Full Text] [Related]
32. Effects of a 5-HT2 receptor agonist, DOI (2,5-dimethoxy-4-iodoamphetamine), and antagonist, ketanserin, on the performance of rats on a free-operant timing schedule.
Body S; Kheramin S; Ho MY; Miranda F; Bradshaw CM; Szabadi E
Behav Pharmacol; 2003 Dec; 14(8):599-607. PubMed ID: 14665977
[TBL] [Abstract][Full Text] [Related]
33. Effect of nicotine cessation on the central serotonergic systems in mice: involvement of 5-HT(2) receptors.
Yasuda K; Suemaru K; Araki H; Gomita Y
Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):276-81. PubMed ID: 12172711
[TBL] [Abstract][Full Text] [Related]
34. DOI and alpha-methylserotonin: comparative vascular and nonvascular smooth muscle effects and central 5-hydroxytryptamine2 receptor affinities.
Cohen ML; Johnson MP; Schenck KW; Susemichel A; Wainscott DB; Robertson DW; Nelson DL
J Pharmacol Exp Ther; 1993 Aug; 266(2):943-9. PubMed ID: 8355216
[TBL] [Abstract][Full Text] [Related]
35. Paradoxical increase of 5-hydroxytryptamine2 receptors and 5-hydroxytryptamine2 receptor mRNA in cerebellar granule cells after persistent 5-hydroxytryptamine2 receptor stimulation.
Akiyoshi J; Hough C; Chuang DM
Mol Pharmacol; 1993 Mar; 43(3):349-55. PubMed ID: 8383800
[TBL] [Abstract][Full Text] [Related]
36. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
Wang CD; Gallaher TK; Shih JC
Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
[TBL] [Abstract][Full Text] [Related]
37. The alpha2 adrenoreceptor agonist clonidine suppresses evoked and spontaneous seizures, whereas the alpha2 adrenoreceptor antagonist idazoxan promotes seizures in amygdala-kindled kittens.
Shouse MN; Scordato JC; Farber PR; de Lanerolle N
Brain Res; 2007 Mar; 1137(1):58-68. PubMed ID: 17214976
[TBL] [Abstract][Full Text] [Related]
38. Regulation of 5-hydroxytryptamine2 (5-HT2) receptor expression in cultured rat aortic smooth muscle cells by SR 46349B, a selective 5-HT2 receptor antagonist.
Rinaldi-Carmona M; Prabonnaud V; Bouaboula M; Poinot-Chazel C; Casellas P; Le Fur G; Herbert JM
J Biol Chem; 1994 Jan; 269(1):396-401. PubMed ID: 8276825
[TBL] [Abstract][Full Text] [Related]
39. The role of galanin receptors in anticonvulsant effects of low-frequency stimulation in perforant path-kindled rats.
Sadegh M; Mirnajafi-Zadeh J; Javan M; Fathollahi Y; Mohammad-Zadeh M; Jahanshahi A; Noorbakhsh SM
Neuroscience; 2007 Dec; 150(2):396-403. PubMed ID: 17993248
[TBL] [Abstract][Full Text] [Related]
40. Suppressive effects of L-5-hydroxytryptophan in a feline model of photosensitive epilepsy.
Wada Y; Hasegawa H; Nakamura M; Yamaguchi N
Brain Res; 1991 Jun; 552(1):8-12. PubMed ID: 1913184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
